Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Enveric Biosciences, Inc. - Common Stock (NQ:ENVB)

1.690 -0.060 (-3.43%)
Streaming Delayed Price Updated: 11:59 AM EDT, Mar 18, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Enveric Biosciences, Inc. - Common Stock

< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance"
Excitement around psychedelics grows as major U.S. exchanges make room for more companies in the sector. On Friday, 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Akebia Therapeutics (NASDAQ:AKBA... 
Via Benzinga
Watch CV Sciences & Lyphe Group On The Benzinga Cannabis Hour
Benzinga’s Cannabis Hour is a live show for cannabis investors. On Thursday’s show, hosts Elliot Lane... 
Via Benzinga
Topics Cannabis
Exposures Cannabis
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Gainers Aerpio Pharmaceuticals (NASDAQ:ARPO) stock moved upwards by 43.27% to $2.45 during Thursday's pre-market session. The market value of their outstanding shares... 
Via Benzinga
Pot Stocks Down In June - Remain +29.6% YTD
There are four cannabis/cannabis-related pot stock categories which I use to provide the clearest overview of the cannabis stock sector that is available anywhere. Below is a comparison of how each... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 17) AbbVie Inc. (NYSE: ABBV)... 
Via Benzinga
Exposures Product Safety
The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 16) Bio-Rad Laboratories, Inc... 
Via Benzinga
Marijuana Drug Stocks: All You Need To Know Is Here!
Eight clinical-stage companies researching the treatment of a wide variety of illnesses using marijuana of which 6 have market capitalizations in excess of $50M and less than $500M and 2 have market... 
Via Talk Markets
Topics Cannabis
Exposures Cannabis
40 Stocks Moving in Monday's Pre-Market Session
Gainers Dynatronics Corporation (NASDAQ: DYNT) shares rose 73.6% to $2.24 in pre-market trading after gaining over 9% on Friday. NanoVibronix Inc (NASDAQ: NAOV) shares rose 45.2... 
Via Benzinga
The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 19) Cytokinetics, Incorporated... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2021
Upgrades For FB Financial Corp (NYSE: 
Via Benzinga
Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies
Irish 5-MeO-DMT Company GH Research Debuts On Nasdaq GH Research, a Dublin-based company studying the potential o... 
Via Benzinga
Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More
Institutional analysts are taking a liking to the industry ... 
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Gainers SCWorx (NASDAQ:WORX) shares rose ... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2021
Upgrades For Toll Brothers Inc (NYSE: 
Via Benzinga
60 Biggest Movers From Yesterday
Gainers Marin Software Incorporated (NASDAQ: MRIN) surged 96.9% to close at $7.50. Marin Software, last week, announced it has added the ability to manage Instacart Ads to its... 
Via Benzinga
Privately Owned MagicMed Industries Inc. is Psyched to Join Forces with Public Pharma Co. Enveric
MagicMed Industries Inc., a privately-held biotech company, recently announced its agreement to an acquisition by Enveric Biosciences (NASDAQ: ENVB). This joint venture may be the... 
Via Benzinga
EXCLUSIVE: MagicMed CEO On Psychedelics Company's 'Secret Sauce,' M&A Deal With Enveric Biosciences
MagicMed Industries' focus is on creating new molecules based on psychedelics, said CEO Dr. Joseph Tucker — bu... 
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Dicerna Pharmaceuticals (NASDAQ:DRNA 
Via Benzinga
Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility
The Nasdaq welcomed its third psychedelics company this week, with 
Via Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session
Gainers Scopus BioPharma (NASDAQ:SCPS) stock rose 101.34% to $12.0 during Monday's regular session. As of 12:30 EST, this security is trading at a volume of 17.5... 
Via Benzinga
35 Stocks Moving In Monday's Mid-Day Session
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares jumped 123.7% to $13.33 after the company reported the FDA approval of IND application for CpG-STAT3siRNA, its distinctive... 
Via Benzinga
Exposures Product Safety
52 Biggest Movers From Yesterday
Gainers Scopus BioPharma Inc. (NASDAQ: SCPS) shares climbed 72% to close at $10.25 on Monday after the company reported the FDA approval of IND application for CpG-STAT3siRNA,... 
Via Benzinga
Exposures Product Safety
Another Psychedelics Company Joins 'Exclusive Nasdaq Group' With Enveric's Acquisition Of MagicMed Industries
CBD-focused biotechnology company Enveric Biosciences (NASDAQ:... 
Via Benzinga
30 Stocks Moving In Friday's Mid-Day Session
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares jumped 105.4% to $54.23 after the company announced new results from a Phase 2 study evaluating its lead drug candidate, ANVS401,... 
Via Benzinga
48 Biggest Movers From Friday
Gainers Annovis Bio, Inc. (NASDAQ: ANVS) shares surged 127.3% to close at $60.00 on Friday after the company announced new results from a Phase 2 study evaluating its lead drug... 
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Gainers Enveric Biosciences (NASDAQ:ENVB) stock rose 16.87% to $2.84 during Friday's pre-market session. The company's, Q1 earnings came out 3 days ago.... 
Via Benzinga
21 Stocks Moving in Friday's Pre-Market Session
Gainers Enveric Biosciences, Inc. (NASDAQ: ENVB) rose 13.2% to $2.75 in pre-market trading after climbing over 11% on Thursday. The company recently reported a Q1 loss of $0.20... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Gainers Enveric Biosciences (NASDAQ:ENVB)... 
Via Benzinga
The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 13) Alexion Pharmaceuticals, Inc... 
Via Benzinga
Exposures Product Safety
< Previous 1 2
...
5 6 7 8 9 10 11 12 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.